Adding Colchicine to Tocilizumab in Patients With Severe COVID-19 Pneumonia.
Clinical trial NCT05118737 · UNKNOWN
Trial details
- NCT number
- NCT05118737
- Sponsor
- Hamad Medical Corporation
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-01
- Primary completion
- 2022-04-30
- Enrollment
- 230
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.